Literature DB >> 18541660

The fibrinogen- and fibronectin-binding domains of Staphylococcus aureus fibronectin-binding protein A synergistically promote endothelial invasion and experimental endocarditis.

Lionel Piroth1, Yok-Ai Que, Eleonora Widmer, Alexandre Panchaud, Stéphane Piu, José M Entenza, Philippe Moreillon.   

Abstract

Staphylococcus aureus experimental endocarditis relies on sequential fibrinogen binding (for valve colonization) and fibronectin binding (for endothelial invasion) conferred by peptidoglycan-attached adhesins. Fibronectin-binding protein A (FnBPA) reconciles these two properties--as well as elastin binding--and promotes experimental endocarditis by itself. Here we attempted to delineate the minimal subdomain of FnBPA responsible for fibrinogen and fibronectin binding, cell invasion, and in vivo endocarditis. A large library of truncated constructs of FnBPA was expressed in Lactococcus lactis and tested in vitro and in animals. A 127-amino-acid subdomain spanning the hinge of the FnBPA fibrinogen-binding and fibronectin-binding regions appeared necessary and sufficient to confer the sum of these properties. Competition with synthetic peptides could not delineate specific fibrinogen- and fibronectin-binding sites, suggesting that dual binding arose from protein folding, irrespective of clearly defined binding domains. Moreover, coexpressing the 127-amino-acid subdomain with remote domains of FnBPA further increased fibrinogen binding by > or =10 times, confirming the importance of domain interactions for binding efficacy. In animals, fibrinogen binding (but not fibronectin binding) was significantly associated with endocarditis induction, whereas both fibrinogen binding and fibronectin binding were associated with disease severity. Moreover, fibrinogen binding also combined with fibronectin binding to synergize the invasion of cultured cell lines significantly, a feature correlating with endocarditis severity. Thus, while fibrinogen binding and fibronectin binding were believed to act sequentially in colonization and invasion, they appeared unexpectedly intertwined in terms of both functional anatomy and pathogenicity (in endocarditis). This unforeseen FnBPA subtlety might bear importance for the development of antiadhesin strategies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18541660      PMCID: PMC2493224          DOI: 10.1128/IAI.00405-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides.

Authors:  C Signäs; G Raucci; K Jönsson; P E Lindgren; G M Anantharamaiah; M Höök; M Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 2.  Staphylococcus aureus infections.

Authors:  F D Lowy
Journal:  N Engl J Med       Date:  1998-08-20       Impact factor: 91.245

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Conformational changes in the fibronectin binding MSCRAMMs are induced by ligand binding.

Authors:  K House-Pompeo; Y Xu; D Joh; P Speziale; M Höök
Journal:  J Biol Chem       Date:  1996-01-19       Impact factor: 5.157

Review 5.  Microbial adhesins recognizing extracellular matrix macromolecules.

Authors:  J M Patti; M Höök
Journal:  Curr Opin Cell Biol       Date:  1994-10       Impact factor: 8.382

6.  Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization.

Authors:  Louise M O'Brien; Evelyn J Walsh; Ruth C Massey; Sharon J Peacock; Timothy J Foster
Journal:  Cell Microbiol       Date:  2002-11       Impact factor: 3.715

7.  Natural history of aortic valve endocarditis in rats.

Authors:  E Héraïef; M P Glauser; L R Freedman
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

8.  Pathogenic bacteria attach to human fibronectin through a tandem beta-zipper.

Authors:  Ulrich Schwarz-Linek; Jörn M Werner; Andrew R Pickford; Sivashankarappa Gurusiddappa; Jung Hwa Kim; Ewa S Pilka; John A G Briggs; T Sebastian Gough; Magnus Höök; Iain D Campbell; Jennifer R Potts
Journal:  Nature       Date:  2003-05-08       Impact factor: 49.962

9.  Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus.

Authors:  D McDevitt; P Francois; P Vaudaux; T J Foster
Journal:  Mol Microbiol       Date:  1994-01       Impact factor: 3.501

10.  A monoclonal antibody enhances ligand binding of fibronectin MSCRAMM (adhesin) from Streptococcus dysgalactiae.

Authors:  P Speziale; D Joh; L Visai; S Bozzini; K House-Pompeo; M Lindberg; M Höök
Journal:  J Biol Chem       Date:  1996-01-19       Impact factor: 5.157

View more
  31 in total

1.  Amino acid polymorphisms in the fibronectin-binding repeats of fibronectin-binding protein A affect bond strength and fibronectin conformation.

Authors:  Nadia N Casillas-Ituarte; Carlos H B Cruz; Roberto D Lins; Alex C DiBartola; Jessica Howard; Xiaowen Liang; Magnus Höök; Isabelle F T Viana; M Roxana Sierra-Hernández; Steven K Lower
Journal:  J Biol Chem       Date:  2017-04-11       Impact factor: 5.157

2.  Staphylococcus aureus host cell invasion and virulence in sepsis is facilitated by the multiple repeats within FnBPA.

Authors:  Andrew M Edwards; Jennifer R Potts; Elisabet Josefsson; Ruth C Massey
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

Review 3.  Infective endocarditis.

Authors:  Yok-Ai Que; Philippe Moreillon
Journal:  Nat Rev Cardiol       Date:  2011-04-12       Impact factor: 32.419

4.  Whole genome sequence and phenotypic characterization of a Cbm+ serotype e strain of Streptococcus mutans.

Authors:  A Avilés-Reyes; I A Freires; J K Kajfasz; D Barbieri; J H Miller; J A Lemos; J Abranches
Journal:  Mol Oral Microbiol       Date:  2018-04-17       Impact factor: 3.563

5.  Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis.

Authors:  Tiago Rafael Veloso; Aziz Chaouch; Thierry Roger; Marlyse Giddey; Jacques Vouillamoz; Paul Majcherczyk; Yok-Ai Que; Valentin Rousson; Philippe Moreillon; José Manuel Entenza
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

6.  Proteomic and transcriptomic profiling of Staphylococcus aureus surface LPXTG-proteins: correlation with agr genotypes and adherence phenotypes.

Authors:  Mathilde Ythier; Grégory Resch; Patrice Waridel; Alexandre Panchaud; Aurélie Gfeller; Paul Majcherczyk; Manfredo Quadroni; Philippe Moreillon
Journal:  Mol Cell Proteomics       Date:  2012-07-25       Impact factor: 5.911

7.  Molecular characterization of endocarditis-associated Staphylococcus aureus.

Authors:  Cara Nethercott; Amanda N Mabbett; Makrina Totsika; Paul Peters; Juan C Ortiz; Graeme R Nimmo; Geoffrey W Coombs; Mark J Walker; Mark A Schembri
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

8.  New perspectives of infections in cardiovascular disease.

Authors:  Ignatius W Fong
Journal:  Curr Cardiol Rev       Date:  2009-05

9.  Genetic and molecular predictors of high vancomycin MIC in Staphylococcus aureus bacteremia isolates.

Authors:  Natasha E Holmes; John D Turnidge; Wendy J Munckhof; J Owen Robinson; Tony M Korman; Matthew V N O'Sullivan; Tara L Anderson; Sally A Roberts; Sanchia J C Warren; Geoffrey W Coombs; Hui-Leen Tan; Wei Gao; Paul D R Johnson; Benjamin P Howden
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

10.  Heterologous expression of Streptococcus mutans Cnm in Lactococcus lactis promotes intracellular invasion, adhesion to human cardiac tissues and virulence.

Authors:  Irlan A Freires; Alejandro Avilés-Reyes; Todd Kitten; P J Simpson-Haidaris; Michael Swartz; Peter A Knight; Pedro L Rosalen; José A Lemos; Jacqueline Abranches
Journal:  Virulence       Date:  2016-06-03       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.